Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Mayasah Al-Nema"'
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 58 (2022)
Abstract Existing medications i.e. the antipsychotic drugs are known to be effective in treating only the positive symptoms of schizophrenia, while being ineffective on negative and cognitive symptoms of the disease. In addition, these medications ca
Externí odkaz:
https://doaj.org/article/648a9daabe354670a5b0333d58b423b0
Autor:
Mayasah Al-Nema, Anand Gaurav, Ming Tatt Lee, Patrick Okechukwu, Piyarat Nimmanpipug, Vannajan Sanghiran Lee
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0278216 (2022)
Phosphodiesterase 1B (PDE1B) and PDE10A are dual-specificity PDEs that hydrolyse both cyclic adenosine monophosphate and cyclic guanosine monophosphate, and are highly expressed in the striatum. Several reports have suggested that PDE10A inhibitors m
Externí odkaz:
https://doaj.org/article/d8d620f12af64354b6500912431a3fdc
Autor:
Marwan Abdelmahmoud Abdelkarim Maki, Palanirajan Vijayaraj Kumar, Shiau-Chuen Cheah, Yeong Siew Wei, Mayasah Al-Nema, Omer Bayazeid, Abu Bakar Bin Abdul Majeed
Publikováno v:
ACS Omega, Vol 4, Iss 5, Pp 8767-8777 (2019)
Externí odkaz:
https://doaj.org/article/00beb3e5bd5a4762bfb0b8dabbb32bca
Publikováno v:
Heliyon, Vol 6, Iss 9, Pp e04856- (2020)
Inhibition of phosphodiesterase 4 (PDE4) is a promising therapeutic approach for the treatment of inflammatory pulmonary disorders, i.e. asthma and chronic obstructive pulmonary disease. However, the treatment with non-selective PDE4 inhibitors is as
Externí odkaz:
https://doaj.org/article/aa1a46c3849647e7b559446e27be02a1
Publikováno v:
Current Topics in Medicinal Chemistry. 22:2190-2206
Abstract: Over the last two decades computational technologies have always played a crucial role in anti-viral drug development. Whenever a virus spreads and becomes a threat to global health it brings along the challenge to develop new therapeutics
Autor:
Mayasah Al-Nema, Anand Gaurav
Publikováno v:
Jordan Journal of Pharmaceutical Sciences. 15:239-257
Background: Schizophrenia is considered one of the top 10 conditions that cause disability worldwide. Regardless of its low prevalence, it negatively impacts the quality of life not only for patients but also for families and society. The present ant
Autor:
Mayasah Al-Nema, Anand Gaurav, Vannajan Sanghiran Lee, Baskaran Gunasekaran, Ming Tatt Lee, Patrick Okechukwu, Piyarat Nimmanpipug
Publikováno v:
RSC Advances. 12:1576-1591
Phosphodiesterase10A (PDE10A) is a potential therapeutic target for the treatment of several neurodegenerative disorders.
Publikováno v:
Computers in Biology and Medicine. 159:106869
Autor:
Anand Gaurav, Mayasah Al-Nema
Publikováno v:
Current Topics in Medicinal Chemistry. 20:2404-2421
Schizophrenia is a severe mental disorder that affects more than 1% of the population worldwide. Dopamine system dysfunction and alterations in glutamatergic neurotransmission are strongly implicated in the aetiology of schizophrenia. To date, antips
Publikováno v:
Current Trends in Biotechnology and Pharmacy. 14:1-10